1. |
|
|
2. |
|
|
3. |
- Escala-Garcia, Maria, et al.
(författare)
-
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
- 2020
-
Ingår i: Nature Communications. - : NATURE PUBLISHING GROUP. - 2041-1723. ; 11:1
-
Tidskriftsartikel (refereegranskat)abstract
- Identifying the underlying genetic drivers of the heritability of breast cancer prognosis remains elusive. We adapt a network-based approach to handle underpowered complex datasets to provide new insights into the potential function of germline variants in breast cancer prognosis. This network-based analysis studies similar to 7.3 million variants in 84,457 breast cancer patients in relation to breast cancer survival and confirms the results on 12,381 independent patients. Aggregating the prognostic effects of genetic variants across multiple genes, we identify four gene modules associated with survival in estrogen receptor (ER)-negative and one in ER-positive disease. The modules show biological enrichment for cancer-related processes such as G-alpha signaling, circadian clock, angiogenesis, and Rho-GTPases in apoptosis.
|
|
4. |
- Gkoutzamanis, V. G., et al.
(författare)
-
Conceptual design and energy storage positioning aspects for a hybrid-electric light aircraft
- 2020
-
Ingår i: Proceedings of the ASME Turbo Expo. - : American Society of Mechanical Engineers (ASME). - 9780791884140
-
Konferensbidrag (refereegranskat)abstract
- This work focuses on the feasibility of a 19-passenger hybrid-electric aircraft, to serve the short-haul segment within the 200-600 nautical miles. Its ambition is to answer some dominating research questions, during the evaluation and design of aircraft based on electric propulsion architectures. The potential entry into service of such aircraft is foreseen in 2030. A literature review is performed, to identify similar concepts that are under research and development. After the requirements definition, the first level of conceptual design is employed. Based on a set of assumptions, a methodology for the sizing of the hybrid-electric aircraft is described to explore the basis of the design space. Additionally, a methodology for the energy storage positioning is provided, to highlight the multidisciplinary aspects between the sizing of an aircraft, the selected architecture (series/parallel partial hybrid) and the energy storage operational characteristics. The design choices are driven by the aim to reduce CO2 emissions and accommodate boundary layer ingestion engines, with aircraft electrification. The results show that it is not possible to fulfill the initial design requirements (600 nmi) with a fully-electric aircraft configuration, due to the farfetched battery necessities. It is also highlighted that compliance with airworthiness certifications is favored by switching to hybrid-electric aircraft configurations and relaxing the design requirements (targeted range, payload, battery technology). Finally, the lower degree of hybridization (40%) is observed to have a higher energy efficiency (12% lower energy consumption and larger CO2 reduction), compared to the higher degree of hybridization (50%), with respect to the conventional configuration.
|
|
5. |
|
|
6. |
- Liu, JJ, et al.
(författare)
-
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
- 2020
-
Ingår i: Scientific reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 10:1, s. 9688-
-
Tidskriftsartikel (refereegranskat)abstract
- In breast cancer, high levels of homeobox protein Hox-B13 (HOXB13) have been associated with disease progression of ER-positive breast cancer patients and resistance to tamoxifen treatment. Since HOXB13 p.G84E is a prostate cancer risk allele, we evaluated the association between HOXB13 germline mutations and breast cancer risk in a previous study consisting of 3,270 familial non-BRCA1/2 breast cancer cases and 2,327 controls from the Netherlands. Although both recurrent HOXB13 mutations p.G84E and p.R217C were not associated with breast cancer risk, the risk estimation for p.R217C was not very precise. To provide more conclusive evidence regarding the role of HOXB13 in breast cancer susceptibility, we here evaluated the association between HOXB13 mutations and increased breast cancer risk within 81 studies of the international Breast Cancer Association Consortium containing 68,521 invasive breast cancer patients and 54,865 controls. Both HOXB13 p.G84E and p.R217C did not associate with the development of breast cancer in European women, neither in the overall analysis (OR = 1.035, 95% CI = 0.859–1.246, P = 0.718 and OR = 0.798, 95% CI = 0.482–1.322, P = 0.381 respectively), nor in specific high-risk subgroups or breast cancer subtypes. Thus, although involved in breast cancer progression, HOXB13 is not a material breast cancer susceptibility gene.
|
|
7. |
- Skribek, M, et al.
(författare)
-
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting
- 2020
-
Ingår i: Cancers. - : MDPI AG. - 2072-6694. ; 12:12
-
Tidskriftsartikel (refereegranskat)abstract
- There is lack of data addressing the intracranial (IC) efficacy of immune checkpoint inhibitors (ICIs) on brain metastases (BM) in non-small cell lung cancer (NSCLC). This patient category is underrepresented in randomized clinical trials. We retrospectively collected clinical data on patients with non-oncogenic driven NSCLC with BM who were treated with ICIs at two medical oncology institutes in Sweden and Greece from 2016 to 2019. IC efficacy was assessed in patients who had not received local treatment for BM less than three months prior to the initiation of ICIs and had adequate radiological evaluation. We screened 280 patients, of which 51 had BM. BM was an independent predictor for inferior PFS (HR = 2.27; 95% CI, 1.53–3.36) but not OS (HR = 1.58; 95% CI, 0.97–2.60) for the whole patient population. IC response assessment was done on 33 patients. IC objective response rate (ORR) was 24.2%. The presence of neurological symptoms related to BM did not affect IC ORR (p = 0.48). High PD-L1 levels from extracranial biopsies were not a predictive factor for IC ORR (p = 0.13). ICIs are active in NSCLC patients with BM regardless of the presence of neurological symptoms and can achieve durable IC disease stabilization in a subgroup of patients.
|
|